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The process of kidney stone formation depends on an imbalance between excretion of water and insoluble stone-forming salts, leading to high concentrations that supersaturate urine and inner medullary collecting duct (IMCD) fluid. For common calcium-containing stones, a critical mechanism that has been proposed for integrating water and calcium salt excretions is activation of the cell surface calcium-sensing receptor (CaSR) on the apical membranes of IMCD cells. High deliveries of calcium into the IMCD would be predicted to activate CaSR, leading to reduced membrane abundance of aquaporin-2, thereby limiting water conservation and protecting against stone formation. We have tested this hypothesis in 16 idiopathic hypercalciuric calcium stone formers and 14 matched normal men and women in the General Clinical Research Center. Subjects were fed identical diets; we collected 14 urine samples at 1-h intervals during a single study day, and one sample overnight. Hypercalciuria did not increase urine volume, so urine calcium molarity and supersaturation with respect to calcium oxalate and calcium phosphate rose proportionately to calcium excretion. Thus CaSR modulation of urine volume via IMCD CaSR activation does not appear to be an important mechanism of protection against stone formation. The overnight period, one of maximal water conservation, was a time of maximal stone risk and perhaps a target of specific clinical intervention. idiopathic hypercalciuria; kidney calculi; calcium oxalate; calcium phosphate EVEN THOUGH THE MOST COMMON kind of kidney stones, those composed of calcium oxalate (CaOx), grow outside the kidney over regions of inner medullary and papillary interstitial apatite deposits (10) , the process depends upon high concentrations of insoluble salts achieved via differential excretion rates for relevant ligands, i.e., calcium, oxalate, phosphate, and water. In patients who form calcium phosphate stones (11) , apatite deposits form in inner medullary collecting ducts (IMCD) and terminal Bellini ducts (BD), presumably for the same reasons, a lack of balance between excretion of ligands and of water leading to high concentrations that supersaturate urine and IMCD or BD fluid. That stones and deposits are not rare makes clear that the integration between water conservation and renal excretion of poorly soluble salts can be quite imperfect.
One critical mechanism that has been proposed for integrating water and calcium salt excretions is activation of the cell surface calcium-sensing receptor (CaSR) on the apical membranes of IMCD principal cells (2, 19) . When activated, the CaSR reduces membrane abundance of aquaporin-2 and thereby the rate of water reabsorption (23) . Since many calcium stone formers are hypercalciuric, probably because of a combination of genetic predisposition and diet (6, 15, 30) , high deliveries of calcium into the IMCD would be predicted to limit water conservation there, protecting against stones and intratubular deposits (2, 12, 25) . Although the mechanisms linking calcium ion concentration to aquaporin membrane abundance are well supported by experiments in cells and whole animals (3, 8, 12, 23) , the relevance of the mechanism to humans with calcium kidney stones is not as yet well studied.
To the extent that the apical IMCD CaSR is indeed modulating water reabsorption to prevent the translation of hypercalciuria into proportional increases in urine calcium molarity, we should be able to show that urine calcium molarity does not rise proportionately to urine calcium excretion because urine volume rises; in other words, urine volume should, to some extent, "keep pace" with hypercalciuria. Another prediction is that urine osmolality should be lower in stone formers with hypercalciuria than in normal people if conditions of diet were matched in a General Clinical Research Center (GCRC) environment.
To test these predictions experimentally, we have used a protocol described elsewhere (31, 32) in which calcium stone formers with idiopathic hypercalciuria (IHSF) as their only detectable systemic abnormality, and reasonably well matched normal men and women (N), were fed identical diets throughout a single-day study, and urine samples were collected 15 times during that day. From this data, we are able to test both predictions. As well, we satisfy a perhaps mundane curiosity clinicians might express concerning when in the day's cycle molarities, and therefore supersaturation (SS) and stone risk, are highest.
METHODS

Protocol
Subjects were studied in the GCRC at the University of Chicago over 14 h as previously described (31, 32) . The study was approved by the Institutional Review Board at the University of Chicago (protocol 12881A). Briefly, upon admission between 6:00 and 7:00 AM two 1-h fasting urine samples were collected. Subsequently subjects ate three study meals, with hourly urine collections until 3 h after the last meal. In addition, a final overnight urine sample was collected from the time the subjects left the GCRC until and including the first void the next morning (ϳ10 h) for a total of 15 urine samples. Subjects were instructed not to eat anything during the overnight period and to limit fluids to water only.
Diet
The study diet consisting of three isocaloric meals was designed to contain calcium, phosphorus, and sodium evenly distributed among the meals (32) . The diet was planned by a nutritionist in the GCRC using Nutritionist IV, version 4.1 software (N-Squared Computing, San Bruno, CA) with the goal of supplying calcium in a 1:1 ratio with phosphorus. The 1,800-kcal base diet provided 1,160 mg calcium and 1,240 mg phosphorus daily, as determined by laboratory analysis of homogenates of the three meals (Covance Laboratories, Madison, WI) (32) . The base diet provided 2,141 mg sodium, 2,427 mg potassium, and 218 mg magnesium each day. Subjects were stratified to one of three caloric levels (1,800, 2,100, or 2,400 kcal/day) according to an estimate of individual energy needs using the Schofield equation (24) .
Laboratory Measurements
Conventional studies. Established urine stone risk factors including calcium, oxalate, citrate, phosphate, magnesium, uric acid, sulfate, ammonium, chloride, potassium, sodium, pH, and urine volume, as well as urea and creatinine, were measured in our laboratory as described elsewhere (1, 18) . SS for CaOx and calcium phosphate (CaP) were calculated using EQUIL 2 (28) .
Urine osmolality. Urine osmolality (U OSM) was measured in two or more of the hourly urine collections for each subject by the Clinical Chemistry Laboratory at the University of Chicago Hospitals using freezing point depression osmometry (model 3D3 osmometer, Advanced Instruments, Norwood, MA). In addition, we estimated the osmolality of all urines according to the following equation:
urea (all measurements in mmol/l). The slightly reduced multiplier of calcium molarity (2.5 vs. 3) was chosen to allow for high-affinity calcium complexations with oxalate, phosphate, and other ligands that would reduce the number of free particles below the expected value of three, and also for the fact that calcium ligands are often divalent. No subject was diabetic, and hourly serum glucose values were all within the normal range (data not shown), so urine glucose was neither measured nor corrected for. In urine samples that had measured UOSM, results correlated well with the estimated values (r 2 ϭ 0.99, P Ͻ 0.001) (Fig. 1) . The regression slope of estimated vs. measured UOSM was 1.069 with an intercept of Ϫ4.086. The estimated UOSM gave somewhat higher values than measured UOSM as indicated by points lying slightly above the diagonal line of identity.
Statistical Analysis
As the data consist of repeated measures on individuals over time, statistical methods for correlated data were used to analyze the mean difference in each laboratory measurement of interest between IHSF and N. In particular, generalized estimating equations (7) utilizing compound symmetric covariance structures were used to compare laboratory values between IHSF and N. To determine whether the mean difference in each laboratory value comparing IHSF and N changed with respect to mealtime, multiplicative interactions between the covariates were modeled. For simplicity, time of day was modeled as fasting, eating (fed), and overnight. In addition, to compare the effect of IHSF by specific mealtimes, we categorized the day into five time periods: fasting, postbreakfast, postlunch, postsupper, and overnight. Interaction terms were tested using multivariate Wald tests. In all cases, empirical SE estimates (29) were used to guarantee consistent variance estimates. All statistical calculations were performed using R (13) and Systat 11 software (Systat Software, Chicago, IL).
RESULTS
Patients and Normal Subjects
Thirty subjects (Table 1) were studied: 16 IHSF (9 men, 7 women) and 14 N (7 men, 7 women). All subjects were adults aged 23-56 yr, and with one exception, previously reported (Table 1) (31, 32) . IH was diagnosed by 24-h urine calcium excretion rates Ͼ140 mg calcium/g urine creatinine on an outpatient free-choice diet (4) and exclusion of all systemic calcium disorders. Stone analysis, reported for 12 IHSF, was a mixture of calcium stone varieties (Table 1) . Four IHSF reported "calcium" stones. N had no personal history of stone disease. No subject was taking medications that could affect stones or mineral metabolism such as thiazide or other diuretic agents, vitamin D, or alkali supplements.
Excretion Rates of Relevant Ligands
Because IHSF were selected for hypercalciuria, their urine calcium excretion exceeded N throughout the day, by about twofold (Fig. 2 , top left; Table 2 ). The crucial stone-forming counter-ions, oxalate and phosphate (Fig. 2 , top middle and right), rose proportionately less, by ϳ50 and 30%, respectively (mean differences are in Table 2 ). Of minor interest, urine magnesium, citrate, and sodium showed minimal differences between IHSF and N ( Fig. 2, bottom; Table 2 ).
Molarities of Relevant Ligands and Urine Volume
The hypothesis we are testing here would predict that urine volume should increase proportionately to hypercalciuria in IHSF so that calcium molarity would remain relatively constant. In fact, this was not the case. Calcium molarity (Fig. 3 , top left; Table 2 ) was higher in IHSF vs. N by ϳ1.5 to 2.5-fold. For example, with breakfast (B to L), IHSF had on average 3.1 mmol Ca/l, while N had 2.4; with lunch, IHSF had 4.0 vs. 2.0 Table 2 ). Because diets were matched, osmolar excretion rates in IHSF and N were indistinguishable (Fig. 4, left) . Despite the marked hypercalciuria and high final urine calcium molarity of IHSF vs. N, urine osmolalities also did not differ between subject groups (Fig. 4, right) .
SS for CaOx and CaP Throughout the Day
Because urine, and therefore collecting duct tubule fluid, is a complex polyelectrolyte solution, the calcium ion activity to which the CaSR presumably responds is best estimated using iterative computer programming that allows for all of the major calcium complexes. We used EQUIL 2 (METHODS). If one is concerned with stone disease, the final and ultimate result of a protective mechanism would be to offset an increase in SS, the driving force of crystallization (5, 26) , which is proportional to the molar activities of calcium and its two key counter-ions: oxalate and phosphate.
SS with respect to CaOx and CaP both were much higher in IHSF vs. N ( Fig. 3, right; Table 3 ). For SS CaOx, the higher values in IHSF vs. N reflect the higher calcium molarity; urine oxalate molarity of IHSF and N did not differ (Table 2) . For SS CaP, calcium molarity also played the major role because neither urine pH (Fig. 3, bottom left) nor urine phosphate molarity (Table 2 ) differed between IHSF and N. Put another way, hypercalciuria was translated into a proportional increase in calcium molarity, and this accounted for the high calcium SS values of IHSF vs. N. Of note, mean SS CaP was on average below 1 in each period in N, and above 1 in each period in IHSF, meaning that the driving force under the controlled conditions of this study would not have supported CaP formation in N.
The overnight period seems to have a special meaning for the IHSF we studied. Calcium molarity, SS CaOx, and SS CaP most exceeded N in that 10-h time frame (Fig. 3, Tables 2 and  3 ). Although this is a necessary consequence of the physiology we have already described, the point is of considerable clinical interest. Of greater interest to us in testing the IMCD CaSR regulation hypothesis is that urine volumes were identical in IHSF vs. N overnight, even though during that period calcium molarity of IHSF urine exceeded N by the greatest margin, nearly threefold.
DISCUSSION
Urine Volume Does Not Increase Proportionately with Calcium Excretion
Although urine calcium excretion of IHSF exceeded N by twofold, urine volumes did not differ. For this reason, calcium molarity of IHSF exceeded N in three of the five periods. The overnight period is of special significance because urine volumes fell equally in IHSF and N vs. daytime, whereas calcium excretion in IHSF exceeded N, so that calcium molarity achieved its highest difference between IHSF and N when urine volume was lowest. In the overnight period, hypercalciuria of ϳ2.5-fold in IHSF vs. N caused a rise of molarity of nearly threefold, and of SS CaP of nearly fivefold, and SS CaOx of over twofold. If IMCD CaSR were really to play a role in preventing abnormal calcium molarity via a linkage between increased calcium molarity and reduced water reabsorption, we can find in our patients no trace of such a phenomenon. Altogether, there is no evidence here to support the proposal of a protective effect of CaSR against stone risk.
Prior Clinical Evidence for an Effect of Calcium on Water Reabsorption
In children with enuresis treated with 1-deamino-8-Darginine vasopressin (DDAVP), many of whom were hypercalciuric, reduced diet calcium increased nocturnal urine aquaporin and osmolality and reduced overnight urine volume (27) . We did not find evidence in our IHSF subjects that might correspond with the higher overnight urine volumes of enuretic children; in our IHSF, overnight urine volume was the same as N. The children all received DDAVP administration, so direct comparison to our work cannot be made. We can find no other studies of enuretic children that confirm the one study reviewed here. We suggest that the children have some additional abnormalities beyond hyper- calciuria, that these abnormalities affect regulation of water balance throughout the day, and that the large group of IHSF subjects, though hypercalciuric, lack such abnormalities and have very high urine calcium molarities at night with no evidence whatever of increased urine volume. One possibility is that these children have CaSR gene variants conferring a greater than normal sensitivity to calcium ions, or perhaps have a higher abundance of CaSR on IMCD apical membranes than do other IHSF subjects, and were, therefore, enuretic and enrolled in the study.
Among N and stone formers, Lam et al. (14) found that very high urine osmolalities and low urine flow rates coexisted with Values are differences in means Ϯ corresponding SE. ON, overnight. *P Ͻ 0.05, †P Ͻ 0.01, ‡P Ͻ 0.001.
total urine calcium concentrations above 5 mmol/l. They concluded that no important defect in renal concentrating ability would be found in that general range, which corresponds well with our highest values for calcium molarity. Their findings therefore accord with ours.
Why CaSR May Not Regulate Water Balance to Match Hypercalciuria
The CaSR is pH sensing, and external pH affects the sensitivity for CaSR activation by calcium ions in HEK 293 cells stably expressing transfected human parathyroid CaSR (20) . The EC 50 value (half-maximal effective concentration of calcium ions) was lowest at pH 9 and rose to a peak of 6 mM at pH 6, then fell to ϳ4 mM at pH 5. Urine pH values in our patients ranged from 5.9 to 6.5, spanning the range of lowest CaSR sensitivity (highest EC 50 ). Moreover, the maximum calcium molarity of the urine was ϳ6 mM. A variety of methods agree that in urine, calcium ions approximate 50% of total measured calcium (16, 22) so at most our urine samples provided signals for calcium ion molarity of 3-3.5 mM, well below the EC 50 at the pH of the urine. Activation of the CaSR would have been modest even at the highest value we achieved.
CaSR sensitivity to calcium ions is reduced by increasing ionic strength, achieved for example, by increased NaCl concentration (21) . The EC 50 for CaSR signaling fell (higher sensitivity) from 3.5 to 2.7 mM (0.8 mM change) when sodium concentration in the medium was reduced from 125 to 85 mM. The sum of sodiumϩpotassium concentrations in our IHSF and N urine samples overnight were 95 and 91 mM, respectively, slightly higher than the 85 mM NaCl in the medium. Daytime values were not remarkably different from these.
Given equivalent sodiumϩpotassium ionic strengths and pH, and pH values ϳ6, one might have predicted that CaSR EC 50 would be ϳ6 mM calcium (the value for pH 6 at a medium NaCl concentration of 125 mM) minus 0.8 mM from the reduction of ionic strength by 40 mM, or 5.2 mM of calcium ions. Signaling in response to hypercalciuria would be modest indeed at the maximal (overnight) calcium molarities our patients achieved, 6 mM total calcium, or 3 mM calcium ion activity. Although not capable of stimulating CaSR efficiently at pH 6, total calcium concentrations of 6 mM create very substantial SS and stone risk. In other words, one cannot extrapolate the findings in vitro to correctly predict effects of CaSR to blunt stone risk from hypercalciuria, even though the in vitro data rather well explain the failure of the CaSR protection hypothesis in IHSF.
Another possibility is that our subjects with IH are all stone forming. Possibly, a relatively insensitive CaSR response led, in them, to a lack of polyuria to compensate for hypercalciuria, and that is why they made stones. If this were true, the main bulk of hypercalciuric people, who do not form stones, may behave more like the enuretic children than like our sample of IHSF. To test this hypothesis critically would require that we study hypercalciuric people without stones and with no family history of stones in a protocol like the present one that eliminates variations in diet.
As a preliminary test of the idea, we performed regression analysis to gauge the effect of urine calcium excretion on urine volume during the overnight period, a most critical interval, and compared our normal subjects to our patients. Individual regressions were not significant (adjusted r 2 0.014 and 0.00 for N and IHSF, respectively). Corresponding standardized coefficients were 0.30 and 0.18; P, not significant for both. In a general linear model with urine volume as the dependent, and urine calcium, age, and weight as covariates, none of the covariates, including calcium excretion, had a significant effect (P value for calcium excretion ϭ 0.41). Adjusted urine volumes did not differ: 80 Ϯ 8 vs. 60 Ϯ 8 ml/h (ϮSE, P ϭ 0.12).
The nonsignificant but nevertheless noted difference in adjusted urine volumes overnight suggests that an experiment like this one but using hypercalciuric people who do not form stones nor have a family history of stones might possibly yield an exciting discovery, of blunted CaSR sensitivity in IHSF. Calcium excretion values for our normal subjects did not overlap with our IHSF, and with larger numbers and uniformly hypercalciuric N, the P value of 0.12 might become significant. On the other hand, the in vitro sensitivity of the CaSR does indeed correspond well with a lack of effect at urine total calcium molarities in the range of 6 mM/l (ϳ3 mM/l calcium ions). Pending more experiments, we choose to limit the implication of our finding, that the CaSR response does not protect against high urine calcium molarity in IH, to patients with IH who form stones, and leave open the possibility that non-stone-forming IH subjects may indeed escape stones by virtue of a more sensitive CaSR.
Stone Risk is Highest at Night
Even though hypercalciuria is most dramatic with meals, the balance between calcium excretion and water excretion is most distorted overnight in relation to stone risk. IHSF subjects excrete more calcium overnight than N in the same amount of urine, so they incur a much greater stone risk vs. N (SS differences of 7.65 and 1.78 for CaOx and CaP, respectively). The effects for CaP SS are perhaps more dramatic in that N are on average undersaturated day and night (Fig. 3) whereas IHSF are supersaturated. Even though CaOx forms the bulk of human stones, CaP as apatite plays a critical role in stone initiation (9) so that the lack of SS CaP in normal people may be remarkably protective. We hesitate to extrapolate from this highly controlled research environment to conditions of clinical practice, but clinicians might want to consider the potentially high risk of overnight SS in their patients. Clinical studies on outpatients, although less easily interpreted in terms of mechanisms, might give a more vigorous picture of just how much higher overnight SS is than daytime, when diet, or even timing of meals, is not controlled. Values are differences in means Ϯ corresponding SE. UA, uric acid. *P Ͻ 0.05, †P Ͻ 0.01, ‡P Ͻ 0.001.
Summary
In IHSF and N subjects studied under exactly fixed-diet intakes, we find no evidence that urine volume is increased by hypercalciuria in such a way as to moderate a rise of urine calcium concentration and consequent stone risk. Prior studies of enuretic hypercalciuric children do not accord with our work, suggesting that these children may have other disorders than those found in adults with IHSF, none of whom have enuresis. In vitro studies of CaSR sensitivity suggest that the reason we cannot find a CaSR effect is that the maximum calcium molarities we observe (ϳ6 -6.5 mM total calcium) are far below the EC 50 for the pH of the urine we measured (6 mM calcium ion activity). Extremes of hypercalciuria such as might be present in malignancy, vitamin D intoxication, and primary hyperparathyroidism (17) may well activate the CaSR mechanism in IMCD and increase urine volume; this work cannot assess this point. Patients with these conditions are frequently hypercalcemic, which may lead to activation of the CaSR on the basolateral side of the thick ascending limb so that polyuria could be produced by that mechanism in addition to or apart from hypercalciuria. All patients studied in this protocol were normocalcemic (data not shown) (31, 32) . Overall, for the vast majority of stone formers, who are IHSF, CaSR modulation of urine volume via IMCD CaSR activation does not appear to be an important mechanism of protection against stone formation. As a consequence, the overnight period, of maximal water conservation, may well be the time of maximal stone risk and perhaps a target of specific clinical intervention.
